> Medication Updates
Treatment for Alcohol Use Disorder
DEA Pharmacists' Manual
FDA Medication Updates
NIMH Mental Health Medications Guide
FDA approves first drug treatment for sexual desire disorder
The FDA has approved Addyi (flibanserin) to treat acquired, generalized hypoactive sectual desire disorder (HSDD) in premenopausal women.
FDA warns of name confusion with Brintellix (vortioxetine) and Brilinta (ticagrelor)
Reports of confusion between Brintellix (an antidepressant) and Brilinta (an anti-blood clotting medication) have resulted in the wrong medication being prescribed or dispensed.
FDA approves Rexulti (brexpiprazole) to treat schizophrenia and as an add-on for major depressive disorder
Rexulti approved to treat adults with schizophrenia and as an add-on with antidepressants for major depressive disorder.
View all tags